| |
|
- Development of Key Opinion Leaders (KOLs) critical to establishing the foundation of a product prior to launch.
- Implementation of selection strategy of (KOLs) based on influence and recognition within given therapeutic area.
- Determine KOLs development as multinational, or specific to product.
- Provide drug information and adverse event reporting.
- Act as liaison to the FDA in the drug approval process.
- Regulatory Consultant Services
- Represent Pharmaceutical Companies to US government organizations including but not limited to FDA and NIH, and NORD, Medicaid, Privatized Insurance Carriers, lobbyists, representatives of Congress, and terminalofficers of the country.
- Liaise between medical and pharmaceutical product companies and SIG or advocacy groups to maximize scientific message and product utility.
Assisting Buyers to:
- Pair buyer interest to market availability.
- Find businesses that meet determined criteria.
- Analyze market potential and licensing and agreement options.
Assisting Sellers to:
- Prepare their business for sale.
- Arrive at a value for their company.
- Screen and select other members of the sales transaction team.
- Prepare necessary documentation in order to market the company.
- Interview, qualify, and inform prospective buyers.
- Attend relevant meetings and complete necessary paperwork.
- Negotiate details, while managing the due diligence process.
- Coordinate closing activities.
- Act as a trusted liaison for pharmaceutical companies needing to establish relationships with patient advocacy groups, or special interest groups (SIGs) necessary for establishing products specific to disease or condition.
- Provide all logistics and planning for Advisory Board meetings, Consultant Meetings, Educational Meetings, and other professional meetings including:
- Program Design
- Site Selection and all logistics for food and meeting arrangements.
- Pre-Meeting Planning
- Transportation
- Attendee Communication
- On-site Management
|
|
|
|
